Abstract:In the first part, the following mechanisms involved in different forms of cell death are considered, with a view to identifying potential therapeutic targets: tumour necrosis factor receptors (TNFRs) and their engagement by tumour necrosis factor-alpha (TNF-α); poly [ADP-ribose] polymerase (PARP)-1 cleavage; the apoptosis signalling kinase (ASK)-c-Jun N-terminal kinase (JNK) axis; lysosomal permeability; activation of programmed necrotic cell death; oxidative stress, caspase-3 inhibition and parthanatos; activation of inflammasomes by reactive oxygen species and the development of pyroptosis; oxidative stress, calcium dyshomeostasis and iron in the development of lysosomal-mediated necrosis and lysosomal membrane permeability; and oxidative stress, lipid peroxidation, iron dyshomeostasis and ferroptosis. In the second part, there is a consideration of the role of lethal and sub-lethal activation of these pathways in the pathogenesis and pathophysiology of neurodegenerative and neuroprogressive disorders, with particular reference to the TNF-α-TNFR signalling axis; dysregulation of ASK-1-JNK signalling; prolonged or chronic PARP-1 activation; the role of pyroptosis and chronic inflammasome activation; and the roles of lysosomal permeabilisation, necroptosis and ferroptosis. Finally, it is suggested that, in addition to targeting oxidative stress and inflammatory processes generally, neuropsychiatric disorders may respond to therapeutic targeting of TNF-α, PARP-1, the Nod-like receptor NLRP3 inflammasome and the necrosomal molecular switch receptor-interacting protein kinase-3, since their widespread activation can drive and/or exacerbate peripheral inflammation and neuroinflammation even in the absence of cell death. To this end, the use is proposed of a combination of the tetracycline derivative minocycline and N-acetylcysteine as adjunctive treatment for a range of neuropsychiatric disorders.

C-Jun N-terminal Kinase Pathway Mediates Lactacystin-induced Cell Death in a Neuronal Differentiated Neuro2a Cell Line.

Cell cycle events mediate lactacystin-induced apoptotic death of neuronal PC12 cells.

Distinct Requirements for P38α and C-Jun N-terminal Kinase Stress-activated Protein Kinases in Different Forms of Apoptotic Neuronal Death

Critical role of c-jun N-terminal protein kinase in promoting mitochondrial dysfunction and acute liver injury

Neuroprotection Against Focal Ischemic Brain Injury by Inhibition of C-Jun N-terminal Kinase and Attenuation of the Mitochondrial Apoptosis-Signaling Pathway.

MAPK/JNK Signalling: a Potential Autophagy Regulation Pathway

The role of calcineurin signaling in microcystin-LR triggered neuronal toxicity

Delayed Inhibition Of C-Jun N-Terminal Kinase Worsens Outcomes After Focal Cerebral Ischemia

The E3 Ubiquitin Ligase Itch Couples Jnk Activation to Tnf Alpha-Induced Cell Death by Inducing C-Flipl Turnover

MAPK/JNK signaling: A potential autophagy regulation pathway.

c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities

Regulation of Linear Ubiquitin Chain Assembly Complex by Caspase-Mediated Cleavage of Rnf31

c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo

Regulation of C-Jun N-terminal Kinase Activation in Hydrogen Peroxide Induced Neurotoxicity

Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells

Regulation of C-Jun N-terminal Kinase, P38 Kinase and AP-1 DNA Binding in Cultured Brain Neurons: Roles in Glutamate Excitotoxicity and Lithium Neuroprotection.

Differences in endoplasmic reticulum stress signalling kinetics determine cell survival outcome through activation of MKP-1

Activation and Involvement of JNK1/2 in Hydrogen Peroxideinduced Neurotoxicity in Cultured Rat Cortical Neurons

Involvement of mitogen-activated protein kinase pathways in N-methyl-D-aspartate-induced excitotoxicity

Dual Leucine Zipper Kinase is Required for Excitotoxicity-Induced Neuronal Degeneration.

Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists